The Curious Case of LSD: a pre-clinical perspective

Value of the Information & Strength of the Argument

The talk provides a valuable synthesis of current preclinical knowledge on LSD, highlighting both established findings and open questions. The speaker’s argumentation is well-structured, moving from molecular to behavioral levels, and she acknowledges the limitations of animal models. She presents a balanced view, discussing the complexity of receptor signaling and the challenges of translating findings to humans. The inclusion of specific studies and researchers adds credibility, and the discussion of non-hallucinogenic compounds offers a nuanced perspective on the field.

Scientific Rigor, Source Quality, Title Accuracy

The talk demonstrates scientific rigor by referencing specific studies and researchers, such as the work from the Roth lab and the recent paper on intracellular 5-HT2A receptors. The speaker also acknowledges the limitations of the field, such as the lack of replication and the differences between rodent and human receptor kinetics. The title accurately reflects the content, and the talk is well-organized. No comments were provided for analysis.

The title accurately reflects the content, which focuses on the preclinical aspects of LSD research, drawing a parallel to the 'curious case' of the reverse timeline of knowledge.

8/10

The talk is given by a PhD researcher at the Paris Brain Institute, presenting a well-structured overview of preclinical LSD research. It includes references to specific studies and researchers, and the speaker demonstrates a nuanced understanding of the field's limitations. However, as a conference talk, it is not peer-reviewed and some claims are simplified.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and overview of the talk's structure
• 02:00The 'Benjamin Button' timeline of LSD research
• 05:00Molecular targets: 5-HT2A receptor and biased signaling
• 10:00Neuroplasticity: dendritic spine growth and synaptic plasticity
• 15:00Brain network models and whole-brain approaches
• 20:00Behavioral effects: head-twitch response and long-term behaviors
• 25:00Debate on necessity of subjective effects and non-hallucinogenic compounds
• 30:00Q&A session on translatability and future directions

• Vargas et al. (2023) - Intracellular 5-HT2A receptor activation — Mentioned as a recent paper showing psychedelics activate intracellular 5-HT2A receptors.
• Roth lab - LSD receptor conformation — Mentioned for insights into the conformational change of 5-HT2A receptor and biased agonism.
• Gulyan lab - Transcriptomic analysis of psychedelics — Mentioned for showing psychedelics induce remodeling of extracellular matrix.
• Alex Kwan lab - Brain regions targeted by psilocybin and ketamine — Mentioned for a paper comparing brain regions targeted by psilocybin and ketamine.
• Gregorio et al. - Dopaminergic VTA neuron firing — Mentioned for showing dose-dependent effects on VTA neuron firing.
• Albert et al. - Correlation between head-twitch response and hallucinogenic potency — Mentioned for demonstrating a positive correlation between head-twitch response and hallucinogenic potency.

• Vargas et al. (2023) - Intracellular 5-HT2A receptor activation — Supports the idea that psychedelics act on intracellular receptors.
• Roth lab - LSD receptor conformation — Provides structural insights into LSD's binding and biased signaling.
• Gulyan lab - Transcriptomic analysis — Shows extracellular matrix remodeling, supporting the metaplasticity model.

• Non-hallucinogenic compounds (e.g., TBG, R70, 2-bromo-LSD) — These compounds challenge the necessity of 5-HT2A activation for therapeutic effects, suggesting alternative mechanisms.